3-iodobenzylguanidine has been researched along with cysteine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, Y; Kobayashi, S; Shirasaka, T; Tateno, M; Utumi, K | 1 |
| Fujii, K; Furukawa, Y; Kobayashi, S; Morii, H; Saito, T; Shirasaka, T; Tateno, M; Utsumi, K; Yasumura, S | 1 |
| Matsuda, H; Mizumura, S; Waragai, M; Yamada, T | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
| Hida, A; Kameyama, M; Morooka, M; Sato, K; Takeuchi, S | 1 |
5 other study(ies) available for 3-iodobenzylguanidine and cysteine
| Article | Year |
|---|---|
[Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
Topics: 3-Iodobenzylguanidine; Brain; Cerebrovascular Circulation; Cysteine; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2008 |
Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Occipital Lobe; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Dementia; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Brain; Chorea; Corpus Striatum; Cysteine; Diabetes Complications; Diabetes Mellitus; Dopamine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neostriatum; Nortropanes; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2016 |